An update in the palliative management of malignant dysphagia

European Journal of Surgical Oncology

Volumn 26, Issue 2, 2000, Pages 116-129

  Kubba, A K ^a,b   Krasner, N ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b University Hospital of Aintree   (United Kingdom)

Author keywords

Malignant dysplasia; Oesophageal cancer; Palliation

Indexed keywords

ANALGESIA; ASPIRATION PNEUMONIA; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; DYSPHAGIA; ESOPHAGUS CANCER; HUMAN; LENGTH OF STAY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STENT; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0034056074     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0754     Document Type: Article

References (128)

1. Mueller JM, Erasmi H, Steltzner M et al. Surgical therapy of oesophageal carcinoma. Br J Surg. 77:1990;845-857.
2. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: Critical review of surgery. Br J Surg. 67:1980;381-390.
3. Mannell A, Becker PJ, Nissenbaum M. Bypass surgery for unresectable oesophageal cancer. Early and late results in 124 cases. Br J Surg. 75:1988;283-286.
4. Siersema PD, Dees J, Van Blankenstein M. Palliation of malignant dysphagia from oesophageal cancer. Scan J Gastroenterol. 33 (Suppl. 225):1998;75-84.
5. Colin CF, Spiro RH. Carcinoma of the cervical oesophagus: changing therapeutic trends. Am J Surg. 148:1984;460-466.
6. Kakegawa T, Yamana H, Ando N. Analysis of surgical treatment for carcinoma situated in the cervical oesophagus. Surgery. 97:1985;150-156.
7. Honkoop P, Siersema PD, Tilanus HW et al. Benign anastomotic strictures after transhiatal oesophagectomy and cervical oesophageogastrostomy: risk factors and management. J Thorac Cardiovasc Surg. 111:1996;1141-1148.
8. Cwikiel W, Tranberg KG, Cwikiel M, Lillo-Gil R. Malignant dysphagia: palliation with oesophageal stents - long term results in 100 patients. Radiology. 207:1998;513-518.
9. Mehran RJ, Duranceau A. The use of endoprosthesis in the palliation of oesophageal carcinoma. Chest Surg Clin North Am. 4:1994;331-346.
10. Mousseau M, Le Forestier J, Barbin J et al. Place de l'intubation a demeure dans le traitement palliatif du cancer de l'oesophage. Arch Fr Mal Appar Dig. 45:1956;208-214.
11. Celestin LR. Permanent intubation in inoperable cancer of the oesophagus and cardia. A new tube. Ann R Coll Surg Engl. 25:1959;165-170.
12. Atkinson M, Ferguson R. Fiberoptic endoscopic palliative intubation of inoperable oesophageo-gastric neoplasm. Br Med J. 1:1977;266-267.
13. Frimberger E. Expanding spiral: a new type of prosthesis for the palliative treatment of malignant oesophageal stenosis. Endoscopy. 15:1983;213-214.
14. Fugger R, Niederle B, Jantsch H et al. Endoscopic tube implantation for the palliation of malignant oesophageal stenosis. Endoscopy. 22:1990;101-104.
15. Lambert R. Oesophageal cancer which stent?, who places it and where. Endoscopy. 27:1995;509-511.
16. Watson A. SEM oesophageal endoprostheses: Which is best? Europ J Gastroenterol Hepatol. 10:1998;363-365.
17. Domschke W, Forster ECH, Matek W et al. Self expanding mesh stent for oesophageal cancer stenosis. Endoscopy. 22:1990;134-136.
18. Bethge N, Knyrim K, Wagner HJ et al. SEMS for the palliation of malignant oesophageal obstruction. A pilot study of eight patients. Endoscopy. 1992;411-415.
19. Moores DWO, Ilves R. Treatment of oesophageal obstruction with covered self expanding oesophageal wallstents. Ann Thorac Surg. 62:1996;963-967.
20. Miyayama S, Matsui O, Kadoya et al. Malignant oesophageal stricture and fistula: Palliative treatment with Polyurethane covered Gianturco stent. J Vasc Intern Radiol. 6:1995;243-248.
21. Acunas B, Rozanes I, Akpinar S et al. Palliation of malignant oesophageal strictures with self expanding Nitinol stents: Drawbacks and complications. Radiology. 199:1996;648-652.
22. Cwikiel W, Stridbeck H, Tranberg KG et al. Malignant oesophageal strictures: Treatment with self expanding Nitinol stent. Radiology. 187:1993;661-665.
23. Cowling MG, Hale H, Grundy A. Management of malignant oesophageal obstruction with self expanding metallic stents. Br J Surg. 85:1998;264-266.
24. De-Palma GD, Matteo ED, Romano G et al. Plastic prosthesis versus SEMS for palliation of inoperable oesophageal thoracic carcinoma: a controlled prospective study. Gastrointest Endosc. 43:1995;478-482.
25. Cwikiel M, Cwikiel W, Albertson M. Palliation of dysphagia in patients with malignant oesophageal strictures. Acta Oncologica. 35:1996;75-79.
26. Dallal HJ, Grieve D, Ghosh S, Penman I, Palmer KR. Expandable metallic stents versus Nd-YAG laser therapy for the palliative treatment of oesophageal cancer: a randomised trial. Gut. 42 (Suppl. 1):1998;TW265.
27. Segalin A, Bonavina A, Carazzone C et al. Improving results of oesophageal stenting: A study on 160 consecutive unselected patients. Endoscopy. 29:1997;701-709.
28. Song HY, Park S, Jung HY et al. Benign and malignant oesophageal strictures: Treatment with a Polyurethane covered retrievable expandable metallic stent. Radiology. 203:1997;747-752.
29. Mallery S, Freeman ML. Removal of an incompletely expanded ultraflex oesophageal stent. Gastrointest Endosc. 43:1996;163-165.
30. Song HY, Choi KC, Kwon HC et al. Oesophageal strictures treatment with a new design of modified Gianturco stent. Radiology. 184:1992;729-734.
31. Schmassmann A, Meyenberger C, Knuchel J et al. Self expanding metal stents in malignant oesophageal obstruction: A comparison between two stent types. Am J Gastroenterol. 92:1997;400-406.
32. Cvetkovski B, Markowitz AJ, Gerdes H et al. Expandable metallic endoprosthesis in malignant dysphagia: A comparison between two stent types. Gastrointest Endosc. 45:1997;169.
33. Hills KS, Chopra KB, Pal A, Westaby D. SEM oesophageal endoprostheses, covered and uncovered: a review of 30 cases. Europ J Gastroenterol Hepatol. 10:1998;371-374.
34. Fan Z, Dai N, Chen L. Expandable thermal shaped memory oesophageal stent: experiences with a new nitinol stent in 129 patients. Gastrointest Endosc. 46:1997;352-357.
35. Raijman I, Siddique I, Ajani J et al. Palliation of malignant dysphagia and fistulae with wallstent: experience with 101 patients. Gastrointest Endosc. 45:1997;215.
36. Raijman I, Siddique I, Ajani J et al. The overall complication rate after oesophageal wallstent is related to the oesophageal location of the lesion. Gastrointest Endosc. 45:1997;214.
37. Raijman I, Siddique I, Ajani J et al. How much luminal dilation (if any) is necessary prior to placement of an oesophageal wallstent? Gastrointest Endosc. 45:1997;213.
38. Cook TA, Dehn TCB. Use of covered SEMS in the treatment of oesophageal carcinoma and tracheo-oesophageal fistula. Br J Surg. 83:1996;1417-1418.
39. Kotsis L, Zubovits K, Vadasz P. Management of malignant tracheo-oesophageal fistulae with cuffed funnel tube. Ann Thorac Surg. 64:1997;355-358.
40. Dua K, Rochling F, Saeian K et al. Use of SEMS for palliation of malignant oesophageal obstruction/tracheo-oesophageal fistula in patients with previously placed oesophageal stents. Gastrointest Endosc. 45:1997;171.
41. Bethge N, Kleist DV, Vakil N. Treatment of oesophageal perforation with a covered expandable metal stent. Gastrointestinal Endosc. 43:1996;161-163.
42. Heindel W, Gossmann A, Fischbach R et al. Treatment of ruptured anastomotic oesophageal stricture following bougienage with a dacron covered Nitinol stent. Cardiovasc Intervent Radiol. 19:1996;431-434.
43. Fleischer DE, Bull-Henry K. A new self expanding metal stent for malignant oesophageal stricture. Gastrointest Endosc. 38:1992;494-496.
44. Song HY, Do YS, Han YM et al. Covered expandable oesophageal metallic stent tubes: Experience in 119 patients. Radiology. 193:1994;689-695.
45. Saxon RR, Barton RE, Katon RM et al. Treatment of malignant oesophageal obstructions with covered metallic Z stents. Long term results in 52 patients. JVIR. 6:1995;747-754.
46. Haringsma J, Ferwerda J, Dekker W, Brom HL. Preliminary experience with a new ultraviolet cured expandable plastic endoprosthesis in the management of malignant oesophageal strictures. Endoscopy. 29:1997;188-191.
47. Chan ACW, Leong HT, Chung SSC et al. Lipoidal as a reliable marker for stenting in malignant oesophageal stricture. Gastrointest Endosc. 50:1994;520-521.
48. Wu WC, Katon RM, Saxon RR. Silicon covered self-expanding metallic stents for the palliation of malignant oesophageal obstruction and oesophageo-respiratory fistula. Experience in 32 patients and a review of the literature. Gastrointest Endosc. 40:1994;22-32.
49. Nwokolo CU, Payne-James JJ, Silk DBA et al. Palliation of malignant dysphagia by ethenol induced tumour necrosis. Gut. 35:1994;299-303.
50. Grund KE, Storek D, Farin G. Endoscopic argon plasma coagulation. First clinical experience in flexible endoscopy. Endosc Surg Allied Tech. 2:1994;42-46.
51. Swain CP, Gong F, Murfitt J et al. Difficulties with placement of oesophageal metal stents and development and testing of new delivery methods of covered stents. Gastrointest Endosc. 41:1995;252.
52. Hochberger J, May A, Bauer R et al. Laser, monopolar, bipolar and argon beamer electrocoagulation for tumour ingrowth and overgrowth of coated and non-coated metal endoprosthesis. Gastrointest Endosc. 41:1995;36.
53. Scheider DM, Siemens M, Cirocco M et al. Photodynamic therapy for the treatment of tumour ingrowth in expandable oesophageal stents. Endoscopy. 29:1997;271-274.
54. Sawant D, Moghissi K. Management of unresectable oesophageal cancer: A review of 537 patients. Eur J Cardio-thorac Surg. 8:1994;113-117.
55. Lundell L, Leth R, Lind T et al. Palliative endoscopic dilatation in carcinoma of the oesophagus and oesophagio-gastric junction. Acta Chir Scand. 155:1989;179-184.
56. Shmueli E, Myzore MF, Burk D et al. Limitations of laser treatment for malignant dysplagia. Br J Surg. 79:1992;778-780.
57. Mitty RD, Cave DR, Birkett DH. One stage retrograde approach to Nd-YAG laser palliation of oesophageal carcinoma. Endoscopy. 28:1996;350-355.
58. Murray FE, Birkett DH, Cave DR. A simplified method of endoscope insertion following oesophageal dilation of malignant oesophageal strictures. (Letter). Gastrointestinal Endosc. 33:1987;268-269.
59. Murray FE, Birkett DH, Cave DR. Cannulation of difficult oesophageal strictures with angiographic catheters. Gastrointestinal Endosc. 33:1987;377-378.
60. Krasner N, Barr H, Skidmore C et al. Palliative laser therapy for malignant dysphagia. Gut. 28:1987;792-798.
61. Loizou LA, Grigg D, Atkinson M et al. A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia. Gastroenterology. 100:1991;1303-1310.
62. Overholt BF. Photodynamic therapy and thermal treatment of oesophageal cancer. Gastrointest Endosc Clin North Am. 3:1992;433-455.
63. Hurley HFG, Cade RJ. Laser phototherapy in the treatment of malignant dysphagia. Aust NZ J Surg. 67:1997;800-803.
64. Mellow MH, Pinkas H. Endoscopic laser therapy for malignancies affecting the oesophagus and gastrooesophageal junction. Arch Intern Med. 145:1985;1443-1446.
65. Barr H, Krasner N, Raouf A, Walker RJ. Prospective randomised trial of laser therapy only and laser therapy followed by endoscopic intubation for the palliation of malignant dysphagia. Gut. 31:1990;252-258.
66. Macken E, Gevers AM, Rutgeerts P. Stents versus endoscopic laser therapy in malignant dysphagia: A comparison of endoscopic palliation of malignant oesophageal stenoses. Surg Endosc. 5:1991;63-67.
67. Fuchs KH, Freys SM, Schaube H et al. Randomised comparison of endoscopic palliation of malignant oesophageal stenoses. Surg Endosc. 5:1991;63-67.
68. Alderson D, Wright PD. Laser recanalisation versus endoscopic intubation in the palliation of malignant dysphagia. Br J Surg. 77:1990;1151-1153.
69. Carter R, Smith JS, Anderson JR. Laser recanalisation versus endoscopic intubation in the palliation of malignant dysphagia. A randomised prospective study. Br J Surg. 79:1992;1167-1170.
70. Loizou L, Grigg D, Atkinson M et al. A prospective comparison of laser therapy and intubation in endoscopic palliation for malignant dysphagia. Gastroenterology. 100:1991;1303-1310.
71. Fleischer D. A comparison of endoscopic laser therapy and BICAP tumour probe therapy for oesophageal carcinoma. Am J Gastroenterol. 82:1987;608-612.
72. Jensen DM, Machicado G, Randall G et al. Comparison of low power Nd-YAG laser and BICAP tumour probe for palliation of oesophageal cancer strictures. Gastroenterology. 94:1988;1263-1270.
73. McIntyre AS, Morris DL, Sloan RL et al. Palliative therapy of malignant oesophageal stricture with the bipolar tumour probe and prosthetic tube. Gastrointest Endosc. 35:1989;531-535.
74. Grund KE, Storek D, Farin G. Endoscopic Argon Plasma Coagulation: first clinical experiences in flexible endoscopy. End Surg. 2:1994;42-46.
75. Schoefl R, Winkelbauer F, Haefner M et al. Two cases of fractured oesophageal Nitinol stents. Endoscopy. 28:1996;518-520.
76. Grund KE, Storek D, Becker HD. Highly flexible self expanding meshed metal stents for palliation of malignant oesophageo-gastric obstruction. Endoscopy. 27:1995;486-494.
77. Van Laethem L, Daviere J, Peny MO et al. Complete eradication of Barrett's mucosa using Argon beam coagulation combined with omeprazole. Gastrointest Endosc. 45:1997;245.
78. Sessler MJ, Becker HD, Flesch I et al. Therapeutic effect of Argon plasma coagulation on small malignant gastro-intestinal tumours. J Cancer Res Clin Oncol. 121:1995;235-238.
79. Farin G, Grund KE. Technology of Argon Plasma Coagulation with particular regard to endoscopic applications. End Surg. 2:1994;71-77.
80. Heindroff H, Wojdemamm M, Bisgaard T, Svendsen LB. Endoscopic palliation of inoperable cancer of the oesophagus or cardia by Argon electrocoagulation. Scan J Gastroenterol. 33:1998;21-23.
81. Palmer M, Miller CW, Van-Way CW, Orton EC. Venous gas embolism associated with argon enhanced coagulation of the liver. J Invest Surg. 6:1993;391-399.
82. McCaughan JS, Williams TE, Bethel BH. Palliation of oesophageal malignancy with photodynamic therapy. Ann Thorac Surg. 40:1985;113-119.
83. MacCaughan JS, Nims A, Guy JT et al. Photodynamic therapy for oesophageal tumours. Arch Surg. 124:1989;74-80.
84. Kubba AK, Krasner N. The emerging role of photodynamic therapy in the management of Barrett's oesophagus. Scand J Gastroenterol. 33:1998;1121-1129.
85. Regula J, MacRobert AJ, Gorchein A, Buonaccorsi GA, Thorpe SM, Spencer GM, Hatfield ARW, Bown SG. Photosensitisation and photodynamic therapy of oesophageal, duodenal and colorectal tumours using 5 aminolaevulinic acid induced protoporhyrin IX - a pilot study. Gut. 36:1995;67-75.
86. Kubba AK, Krasner N. The emerging role of photodynamic therapy in the management of Barrett's oesophagus. Scan J Gastroenterol. 33:1998;1121-1129.
87. Jin M, Yang B, Zhang W, Wang Y. Photodynamic therapy for upper gastrointestinal tumours over the past 10 years. Semin Surg Oncol. 10:1994;111-113.
88. Heier SK, Rothman KA, Heier LM, Rosenthal WS. Photodynamic therapy for obstructing oesophageal cancer: Light dosimetry and randomised comparison with Nd-YAG laser therapy. Gastroenterology. 109:1995;63-72.
89. Lightdale CJ, Heier SK, Marcon NE et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd-GAY laser for palliation of oesophageal cancer: a multicentre randomised trial. Gastrointest Endosc. 42:1995;507-512.
90. Scheider DM, Cirocco M, Haber GB et al. Photodynamic therapy for the treatment of tumour ingrowth in expandable oesophageal stents. Endoscopy. 29:1997;271-274.
91. Kubba AK. Role of photodynamic therapy in the management of gastrointestinal cancer. Digestion. 60:1999;1-10.
92. Petrovich Z, Langholz B, Formenti S et al. Management of carcinoma of the oesophagus: The role of radiotherapy. Am J Clin Oncol. 14:1991;80-86.
93. Albertsson M, Ewers SB, Widmark H et al. Evaluation of the palliative effect of radiotherapy for oesophageal carcinoma. Acta Oncol. 28:1989;267-270.
94. Caspers RJL, Welvaart K, Verkes J et al. The effect of radiotherapy on dysphagia and survival in patients with oesophageal cancer. Radiother Oncol. 12:1988;15-23.
95. Burmeister BH, Deham JW, O'Brien M et al. Combined modality therapy for oesophageal carcinoma: preliminary results from a large Australian multicentre study. Int J Radiation Oncology Biol Phys. 32:1995;997-1006.
96. Raijman I, Siddique I, Ajani J et al. Palliation of malignant dysphagia with chemo-radiation therapy does not increase the rate of serious complications with coated wallstent. Gastrointest Endosc. 45:1997;216.
97. Sterling MJ, Vargo JJ, Zuccaro G et al. Does external beam radiation therapy increase the complication rate of expandable metal stents in patients with malignant dysphagia. Gastrointest Endosc. 45:1997;237.
98. Oliver SE, Robertson CS, Logan RFA et al. What does radiotherapy add to survival over endoscopic intubation alone in inoperable squamous cell oesophageal cancer? Gut. 31:1990;750-752.
99. Cwikiel M, Cwikiel W, Albertsson M. Palliation of dysphagia in patients with malignant oesophageal strictures. Acta Oncologica. 35:1996;75-79.
100. Lipman TO, Mayoral W, Sallout L et al. Endoscopic Nd-YAG laser enhanced intensive multimodality therapy for advanced oesophageal cancer: A 4 year experience. Gastroenterology. 116:1999;G1999.
101. Lee YC, Park SJ, Song SY et al. Effect of chemotherapy and or radiotherapy on the SEMS related complications in malignant oesophageal stricture. Gastroenterology. 116:1999;G1980.
102. Sargeant IR, Tobias JS, Blackman G et al. Radiotherapy enhances laser palliation of malignant dysphagia: a randomised study. Gut. 40:1997;362-369.
103. Rowland CG, Pagliero KM. Intracavitary irradiation in palliation of carcinoma of oesophagus and cardia. Lancet. 2:1985;981-983.
104. Shmueli E, Srivastava E, Dawes PJDK et al. Combination of laser treatment and intraluminal radiotherapy for malignant dysphagia. Gut. 38:1996;803-805.
105. Sander R, Hagenmueller F, Sander C et al. Laser versus laser plus afterloading with iridium 192 in the palliative treatment of malignant stenosis of the oesophagus: a prospective randomised and controlled study. Gastrointest Endosc. 37:1991;433-440.
106. Low DE, Pagliero KM. Prospective randomised clinical trial comparing brachytherapy and laser photoablation for palliation of oesophageal cancer. J Thorac Cardiovasc Surg. 104:1992;173-179.
107. Ludwig D, Dehne A, Burmester E et al. Prognostic factors in patients with malignant oesophageal stenosis and palliative treatment with SEMS. Gastrointest Endosc. 45:1997;194.
108. Kinsman KJ, De Gregorio BT, Katon RM et al. Prior radiation and chemotherapy increase the risk of life threatening complications after insertion of metallic stents for oesophagio-gastric malignancy. Gastrointest Endosc. 43:1996;196-203.
109. Kaneko K, Kurahashi T, Konishi K et al. Metalic stent implantation for local recurrence after chemoradiotherapy of oesophageal carcinoma. Gastroenterology. 116:1999;G1894.
110. Bader M, Ditter HJ, Ultsch B et al. Palliative treatment of malignant stenosis of the upper gastrointestinal tract using a combination of laser and after loading therapy. Endoscopy. 18 (Suppl. 1):1986;27-31.
111. Ruol A, Ancona E, Tomio L et al. Combined chemoradiotherapy and surgery in locally advanced T4 oesophageal carcinoma: A prospective phase II study with cisplatin, etoposide and 45 Gy. J Chemother. 8:1996;60-62.
112. Ancona E, Ruol A, Castoro C et al. First line chemotherapy improves the resection rate and long term survival of locally advanced T4NM0 squamous cell carcinoma of the thoracic oesophagus: final report on 163 consecutive patients with 5 year follow up. Annals of Surgery. 226:1997;714-723.
113. Chung SCS, Leong HT, Choi CYC et al. Palliation of malignant oesophageal obstruction by endoscopic alcohol injection. Endoscopy. 26:1994;275-277.
114. Angelini G, Fratta PA, Aderle A et al. Nd-YAG laser versus polidocanol injection for palliation of oesophageal malignancy: a prospective randomised study. Gastrointest Endosc. 37:1991;607-610.
115. Kozarek RA, Raltz S, Brugge WR et al. Prospective multicentre trial of oesophageal Z stent placement for malignant dysphagia and tracheo-oesophageal fistula. Gastrointest Endosc. 44:1996;562-567.
116. Kozarek RA, Raltz S, Marcon N et al. Use of the 25 mm flanged oesophageal Z stent for malignant dysphagia: a prospective multicentre trial. Gastrointest Endosc. 46:1997;156-160.
117. Spinelli P, Cerrai F, Merona E. Pharyngo-oesophageal prosthesis in malignancies of the cervical oesophagus. Endoscopy. 23:1991;213-214.
118. Loizou LA, Rampton D, Bown SG. Treatment of malignant strictures of the cervical oesophagus by endoscopic intubation using modified endoprostheses. Gastrointestinal Endosc. 36:1992;158-164.
119. Bethge N, Sommer A, Vakil N. A prospective trial of self-expanding metal stents in the palliation of malignant oesophageal strictures near the upper oesophageal strictures near the upper oesophageal sphincter. Gastrointestinal Endosc. 45:1997;300-303.
120. Buset M, Marez BD, Cremer M. Endoscopic palliative intubation of the oesophagus invaded by lung cancer. Gastrointest Endosc. 36:1990;357-359.
121. Dougenis D, Petsas T, Bouboulis N et al. Management of non resectable malignant oesophageal stricture and fistula. Eur J Cardiothorac Surg. 11:1997;38-45.
122. Raijman I, Lynch P. Coated expandable oesophageal stents in the treatment of digestive-respiratory fistulas. Am J Gastroenterol. 92:1997;2188-2189.
123. Ogilvie AL, Dronfield MW, Ferguson R et al. Palliative intubation of oesophageo-gastric neoplasms at fibroptic endoscopy. Gut. 23:1982;1060-1067.
124. De-Gregorio BT, Kinsman K, Katon RM et al. Treatment of oesophageal obstruction from mediastinal compressive tumours with covered SEM Z stents. Gastrointest Endosc. 43:1996;483-489.
125. Vermeijden JR, Bartelsman JFWM, Fockens P et al. SEMSs for palliation of oesophageo-cardial malignancies. Gastrointest Endosc. 41:1995;58-63.
126. Clements WDB, Johnston LR, McIlwrath E et al. Self expanding stents for malignant dysphagia. J R Soc Med. 89:1996;454-456.
127. Leong S, Kortan P, Ray R et al. Transgastric oesophagoscopy with antegrade dilation. Endoscopy. 26:1994;622-624.
128. Winkler WP, Haroutiounian G, Baer JW et al. Transgastric oesophageal bougienage via a feeding gastrostomy. Gastrointest Endosc. 31:1985;277-279.